Abstract
Malaria persists at low levels on Zanzibar despite the use of vector control and case management. We use a metapopulation model to investigate the role of human mobility in malaria persistence on Zanzibar, and the impact of reactive case detection. The model was parameterized using survey data on malaria prevalence, reactive case detection, and travel history. We find that in the absence of imported cases from mainland Tanzania, malaria would likely cease to persist on Zanzibar. We also investigate potential intervention scenarios that may lead to elimination, especially through changes to reactive case detection. While we find that some additional cases are removed by reactive case detection, a large proportion of cases are missed due to many infections having a low parasite density that go undetected by rapid diagnostic tests, a low rate of those infected with malaria seeking treatment, and a low rate of follow up at the household level of malaria cases detected at health facilities. While improvements in reactive case detection would lead to a reduction in malaria prevalence, none of the intervention scenarios tested here were sufficient to reach elimination. Imported cases need to be treated to have a substantial impact on prevalence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NC and AMD were supported by the Bill and Melinda Gates Foundation (OPP1032350). Funding for the RADZEC study was provided by the Swiss Tropical and Public Health Institute and the US President's Malaria Initiative via the US Agency for International Development/Tanzania under the terms of an inter-agency agreement with Centers for Disease Control and Prevention (CDC) and the US Agency for International Development/Tanzania through a cooperative agreement with the MEASURE Evaluation consortium, under the associate cooperative agreement No. AID-621-LA-14-00001 titled Measure Phase III-- Strengthening the monitoring, evaluation and research capacity of the community health and social service programmes in the United Republic of Tanzania. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the President's Malaria Initiative via the US Agency for International Development, or other employing organizations or sources of funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the collection of the data used in this study was obtained from the Zanzibar Medical Research Ethics Committee, the Institutional Review Boards of Tulane University and of the Ifakara Health Institute as well as the Ethics Commission of North-western and Central Switzerland.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in this study are available online at https://github.com/SwissTPH/ZanzibarRCD